• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    3/20/23 2:18:52 PM ET
    $ABR
    $ACER
    $ACRV
    $ALLR
    Real Estate Investment Trusts
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABR alert in real time by email

    Gainers

    • Loyalty Ventures Inc. (NASDAQ:LYLT) gained 121.1% to $0.19. Shares of companies in the broader communication, media & entertainment industry traded higher as stocks rebound from recent weakness stemming from instability concerns in the financial sector, which could impact future Fed policy.
    • Gelesis Holdings, Inc. (NYSE:GLS) gained 82.7% to $0.2010.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 72.5% to $0.1812 after the company said it dosed the first patient in its trial studying advanced solid tumors.
    • Ambipar Emergency Response (NYSE:AMBI) shares climbed 60.5% to $13.18.
    • Lifecore Biomedical, Inc. (NASDAQ:LFCR) gained 60% to $2.67. Lifecore Biomedical, on Friday, reported worse-than-expected Q2 financial results.
    • Acer Therapeutics Inc. (NASDAQ:ACER) jumped 55% to $1.04. EF Hutton reiterated Acer Therapeutics with a Buy and maintained a $7 price target.
    • Biocept, Inc. (NASDAQ:BIOC) gained 47.2% to $0.3472. Biocept engaged a financial advisor to explore strategic alternatives.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) jumped 46% to $1.54.
    • Boxed, Inc. (NASDAQ:BOXD) climbed 43% to $0.1447.
    • New York Community Bancorp, Inc. (NASDAQ:NYCB) gained 40% to $9.18 after the Federal Deposit Insurance Corporation (FDIC) announced NYCB subsidiary Flagstar Bank entered into a purchase agreement for Signature Bridge Bank. Multiple analysts upgraded the stock in the wake of the announcement.
    • Sonim Technologies, Inc. (NASDAQ:SONM) gained 31% to $0.5506.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) jumped 27.5% to $1.2250. Gossamer Bio, on Friday, posted a Q4 loss of $0.59 per share.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) gained 27% to $0.61.
    • Golden Minerals Company (NYSE:AUMN) rose 27% to $0.2578.
    • FG Financial Group, Inc. (NASDAQ:FGF) gained 23.7% to $2.50.
    • SuRo Capital Corp. (NASDAQ:SSSS) shares climbed 19.1% to $3.49. SuRo Capital will commence a modified Dutch Auction tender offer to repurchase up to 3 million shares of its common stock.
    • Lavoro Limited (NASDAQ:LVRO) gained 17.1% to $8.09.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) rose 15% to $14.40.
    • Genelux Corporation (NASDAQ:GNLX) gained 12.9% to $30.82.
    • Franchise Group, Inc. (NASDAQ:FRG) jumped 11.8% to $25.44. Franchise Group revealed the receipt of an unsolicited non-binding proposal to acquire all of its outstanding shares at $30.00 per share in cash.
    • Talos Energy Inc. (NYSE:TALO) gained 10.8% to $13.17 after the company announced a $100 million share repurchase authorization.
    • PacWest Bancorp (NASDAQ:PACW) gained 10.1% to $10.22 after the company provided an update on its liquidity position.
    • Sigma Lithium Corporation (NASDAQ:SGML) climbed 9.6% to $36.49.
    • UMB Financial Corporation (NASDAQ:UMBF) rose 8.8% to $ 63.40.
    • Arbor Realty Trust, Inc. (NYSE:ABR) gained 8.8% to $12.18.
    • iStar Inc. (NYSE:STAR) climbed 8.2% to $7.30.
    • OSI Systems, Inc. (NASDAQ:OSIS) gained 8% to $98.42. OSI Systems secured an award valued at $600 million, which includes 16% value added tax (VAT), from Mexico's Secretaría de la Defensa Nacional (SEDENA) for cargo and vehicle inspection systems and related services.
    • BankUnited, Inc. (NYSE:BKU) gained 6.8% to $22.70.
    • Value Line, Inc. (NASDAQ:VALU) gained 6.7% to $49.47. Value Line recently reported Q3 earnings.
    • FLEETCOR Technologies, Inc. (NYSE:FLT) gained 5.8% to $198.11 after the company announced it entered into a cooperation agreement with the D.E. Shaw Group and also agreed to form an ad hoc Strategic Review Committee.

    Losers

    • Aziyo Biologics, Inc. (NASDAQ:AZYO) fell 57.4% to $1.66 after the company received a determination from the FDA indicating that the company's premarket notification for the CanGaroo RM Antibacterial Envelope is not substantially equivalent.
    • Credit Suisse Group AG (NYSE:CS) shares dipped 52.9% to $0.9465 after UBS agreed to acquire the bank for $3.2 billion.
    • CXApp Inc. (NASDAQ:CXAI) fell 33% to $1.92.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) fell 32.8% to $0.2865.
    • Acrivon Therapeutics, Inc. (NASDAQ:ACRV) dropped 31% to $13.80.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 24.4% to $0.2950. Pear Therapeutics said it is exploring strategic alternatives and said it may seek a reorganization if it is unable to complete a transaction. Credit Suisse, TD Cowen and Chardan Capital downgraded the stock.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) dropped 23.6% to $0.7859 after the company announced a special shareholder meeting to approve a 1-for-5 to 1-for-10 reverse stock split.
    • Bakkt Holdings, Inc. (NASDAQ:BKKT) fell 23.3% to $1.32
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) dropped 23% to $0.2385.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) fell 23% to $0.4675.
    • Omega Therapeutics, Inc. (NASDAQ:OMGA) dropped 21.9% to $7.64.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) dipped 20.7% to $4.32.
    • Home Point Capital Inc. (NASDAQ:HMPT) fell 20.6% to $2.0246.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) dropped 17.2% to $19.17 after the company reported Q4 financial results.
    • CareMax, Inc. (NASDAQ:CMAX) fell 15.5% to $2.5875.
    • Dingdong (Cayman) Limited (NYSE:DDL) dropped 15.3% to $3.3850.
    • PDD Holdings Inc. (NYSE:PDD) fell 13.4% to $79.60 after the company reported worse-than-expected Q4 revenues and a decrease in revenues from merchandise sales.
    • LivePerson, Inc. (NASDAQ:LPSN) dropped 12.9% to $3.6650.
    • Nikola Corporation (NASDAQ:NKLA) fell 9.4% to $1.5401.

    Now Read This: Top 5 Tech Stocks Which You'll Regret Missing This Quarter

    Get the next $ABR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABR
    $ACER
    $ACRV
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    BankUnited Inc.
    $BKU
    4/23/2026$57.00 → $53.00Outperform
    Hovde Group
    PDD Holdings Inc.
    $PDD
    4/17/2026$121.00Neutral → Buy
    Arete
    Talos Energy Inc.
    $TALO
    4/8/2026$16.00Buy → Neutral
    Roth Capital
    Sigma Lithium Corporation
    $SGML
    4/3/2026$17.00Neutral → Buy
    BofA Securities
    Sigma Lithium Corporation
    $SGML
    4/2/2026$17.00Neutral → Buy
    BofA Securities
    PDD Holdings Inc.
    $PDD
    3/27/2026$136.00Neutral → Buy
    Nomura
    Gossamer Bio Inc.
    $GOSS
    3/23/2026Overweight → Neutral
    Cantor Fitzgerald
    MoonLake Immunotherapeutics
    $MLTX
    3/23/2026$24.00Underperform → Outperform
    Wolfe Research
    More analyst ratings

    $ABR
    $ACER
    $ACRV
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRES., SPACELABS HEALTHCARE Constantine W Paul covered exercise/tax liability with 65 shares, decreasing direct ownership by 4% to 1,384 units (SEC Form 4) (for withholding tax)

    4 - OSI SYSTEMS INC (0001039065) (Issuer)

    4/24/26 4:00:05 PM ET
    $OSIS
    Semiconductors
    Technology

    Director Ra Capital Management, L.P. was granted 3,888,888 shares (SEC Form 4)

    4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)

    4/23/26 4:28:10 PM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Klein Mark D

    4 - SURO CAPITAL CORP. (0001509470) (Issuer)

    4/22/26 4:06:16 PM ET
    $SSSS
    Finance: Consumer Services
    Finance

    $ABR
    $ACER
    $ACRV
    $ALLR
    SEC Filings

    View All

    SEC Form DEF 14A filed by Lifecore Biomedical Inc.

    DEF 14A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)

    4/24/26 4:09:37 PM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Gossamer Bio Inc.

    DEFA14A - Gossamer Bio, Inc. (0001728117) (Filer)

    4/24/26 4:02:09 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Gossamer Bio Inc.

    DEF 14A - Gossamer Bio, Inc. (0001728117) (Filer)

    4/24/26 4:01:21 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hovde Group reiterated coverage on BankUnited with a new price target

    Hovde Group reiterated coverage of BankUnited with a rating of Outperform and set a new price target of $53.00 from $57.00 previously

    4/23/26 6:53:43 AM ET
    $BKU
    Savings Institutions
    Finance

    PDD Holdings upgraded by Arete with a new price target

    Arete upgraded PDD Holdings from Neutral to Buy and set a new price target of $121.00

    4/17/26 9:26:04 AM ET
    $PDD
    EDP Services
    Technology

    Talos Energy downgraded by Roth Capital with a new price target

    Roth Capital downgraded Talos Energy from Buy to Neutral and set a new price target of $16.00

    4/8/26 8:30:36 AM ET
    $TALO
    Oil & Gas Production
    Energy

    $ABR
    $ACER
    $ACRV
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for OLPRUVA issued to ACER THERAPEUTICS INC

    Submission status for ACER THERAPEUTICS INC's drug OLPRUVA (ORIG-1) with active ingredient SODIUM PHENYLBUTYRATE has changed to 'Approval' on 12/22/2022. Application Category: NDA, Application Number: 214860, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/23/22 1:58:04 PM ET
    $ACER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Graves Greg M bought $28,125 worth of shares (220 units at $127.83), increasing direct ownership by 0.56% to 39,541 units (SEC Form 4)

    4 - UMB FINANCIAL CORP (0000101382) (Issuer)

    2/3/26 6:29:24 PM ET
    $UMBF
    Major Banks
    Finance

    Director Peterman Tamara bought $19,687 worth of shares (154 units at $127.83), increasing direct ownership by 2% to 10,102 units (SEC Form 4)

    4 - UMB FINANCIAL CORP (0000101382) (Issuer)

    2/3/26 6:26:17 PM ET
    $UMBF
    Major Banks
    Finance

    $ABR
    $ACER
    $ACRV
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dingdong Files Its Annual Report on Form 20-F

    SHANGHAI, April 24, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 24, 2026. The Annual Report can be accessed on the Company's investor relations website at https://ir.100.me. The Company will also provide a hard copy of its Annual Report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.About Dingdong (Cayman) Limited Dingdong is

    4/24/26 7:30:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    OSI Systems Receives $235 Million Homeland Defense Contract

    OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ:OSIS) today announced that its Security division has been awarded an Undefinitized Contract Action (UCA) with a not-to-exceed value of approximately $235 million for the production and integration of a homeland defense over the horizon radar (OTHR) transmit subsystem. The system is designed to enable long‑range tracking of various target types beyond conventional line‑of‑sight limitations. OSI Systems' President and Chief Executive Officer, Ajay Mehra, commented, "This award highlights our strengths in critical radio frequency (RF) engineering, advanced manufacturing, and complex system integration for mission‑critical defense app

    4/23/26 8:30:00 AM ET
    $OSIS
    Semiconductors
    Technology

    The Container Store Launches Nationwide Overhaul Across 98 Stores

    30% category and SKU liquidation required to make way for Bed Bath & Beyond merger The Container Store today announced the launch of a chainwide "Store Changing" event beginning Friday, April 24, as 98 stores nationwide begin resetting selling floors to prepare for the phased integration of Bed Bath & Beyond products. As part of the reset, the Company will liquidate approximately 30% of select categories and SKUs beginning Friday to streamline assortments, improve space productivity and create room for new products expected to arrive in phases later this year. The initiative is a planned step in reimagining the combined in-store experience. "This is a reset with purpose," said Jen Pap

    4/23/26 8:00:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ABR
    $ACER
    $ACRV
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    Bed Bath & Beyond Names Veteran Retail Operator Amy Sullivan President

    Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or the "Company"), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's, and a blockchain asset portfolio, today announced the appointment of Amy Sullivan as President, effective immediately, as the Company accelerates its next phase of disciplined growth. Sullivan is a merchant and operator who built her career across some of retail's most recognized brands, including JCPenney, Kohl's, Lands' End, Express, and Lane Bryant, before joining Kirkland's in 2012, where she rose from divisional merchandise manager to President and CEO. As CEO of The Brand House Collective, the operating entity she led through its transformation

    4/6/26 8:30:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    UPDATE - Bakkt Releases Shareholder Letter and Reports Full Year 2025 Financial Results

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today released a shareholder letter from Chief Executive Officer Akshay Naheta and reported its financial results for the full year ended December 31, 2025. The Company will discuss its results and 2026 strategic priorities at its Investor Day on March 17, 2026. To our Shareholders: Dear Fellow Shareholders, I am writing to you for the first time as CEO of Bakkt. When I joined the company, it was clear that significant rebuilding was required. Bakkt possessed something rare — a deep regulatory foundation and institutional pedigree rooted in its origins within Intercontinental Exchange — but

    3/16/26 6:49:34 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Bakkt Releases Shareholder Letter and Reports Full Year 2025 Financial Results

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today released a shareholder letter from Chief Executive Officer Akshay Naheta and reported its financial results for the full year ended December 31, 2025. The Company will discuss its results and 2026 strategic priorities at its Investor Day on March 17, 2026. To our Shareholders: Dear Fellow Shareholders, I am writing to you for the first time as CEO of Bakkt. When I joined the company, it was clear that significant rebuilding was required. Bakkt possessed something rare — a deep regulatory foundation and institutional pedigree rooted in its origins within Intercontinental Exchange — but

    3/16/26 6:09:59 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    $ABR
    $ACER
    $ACRV
    $ALLR
    Financials

    Live finance-specific insights

    View All

    OSI Systems Announces Third Quarter Conference Call

    OSI Systems, Inc. (NASDAQ:OSIS) will host its quarterly conference call on Monday, May 4, 2026, at 1:30 p.m. PT to discuss its financial results for the quarter ended March 31, 2026. The live webcast will be available in the Investor Relations section of the Company's website at www.osi-systems.com. A replay of the conference call will be available shortly afterward and can also be accessed in the Investor Relations section of the Company's website at www.osi-systems.com. About OSI Systems, Inc. OSI Systems designs and manufactures specialized electronic systems and components for critical applications. The Company operates through three business segments: Security, Optoelectronics an

    4/22/26 8:30:00 AM ET
    $OSIS
    Semiconductors
    Technology

    BankUnited, Inc. Reports 1Q 2026 Net Income of $62 million, $0.83 Diluted EPS

    Chairman, President and Chief Executive Officer Rajinder Singh commented, "Despite a seasonally slow quarter, we continue to gather market share and position the Company for improved profitability and growth." First Quarter Financial Highlights   Quarter Ended   Change From ($ in millions except per share data) March 31, 2026   December 31, 2025   March 31, 2025   December 31, 2025   March 31, 2025 Net income $ 61.9     $ 69.3     $ 58.5     $ (7.4 )   $ 3.4   Diluted EPS

    4/22/26 6:45:00 AM ET
    $BKU
    Savings Institutions
    Finance

    SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

    BOSTON and ROLLE, Switzerland, April 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the first quarter 2026 before U.S. markets open on Tuesday, May 5, 2026. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the websi

    4/21/26 8:00:00 AM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by SuRo Capital Corp.

    SC 13D - SURO CAPITAL CORP. (0001509470) (Subject)

    12/4/24 4:10:31 PM ET
    $SSSS
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Golden Minerals Company

    SC 13G/A - Golden Minerals Co (0001011509) (Subject)

    11/14/24 7:11:10 PM ET
    $AUMN
    Precious Metals
    Basic Materials

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    $ABR
    $ACER
    $ACRV
    $ALLR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at Air Transport Services Group Inc on Jun 7 Indicate?

    Recently, on June 7, 2024, Michael L Berger, a significant figure at Air Transport Services Group Inc, made a notable insider purchase. Berger bought $49,830 worth of shares, acquiring 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units as reported in the SEC Form 4 here. Examining other insider actions within the company can sometimes reveal intriguing patterns that might offer insights for investors. Looking back at previous transactions, we see a series of insider activities at Air Transport Services Group Inc: In March 2024, Dominick Jeffrey A. filed an SEC Form 4, indicating a notable transaction date in which actions were

    6/10/24 12:35:45 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care